Suchergebnisse - "Gu, Jingli"

PubPharm (67)

1

Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma

enthalten in: British journal of haematology | 2024

von Zhu, H. | Liu, J. | Gu, J. | +5

2

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells

enthalten in: Medical oncology (Northwood, London, England) | 2023

von Huang, B. | Liu, H. | Chan, S. | +7

3

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells

enthalten in: Medical oncology | 2023

von Huang, B. | Liu, H. | Chan, S. | +7

4

Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance

enthalten in: Journal of personalized medicine | 2023

von Liu, J. | Huang, B. | Gu, J. | +1

5

Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients : a single center experience

enthalten in: Annals of medicine | 2023

von Li, Y. | Liu, J. | Huang, B. | +3

6

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients : The TM frailty score

enthalten in: Frontiers in oncology | 2023

von Chen, Y. | Gu, J. | Huang, B. | +3

7

Clinical Value of Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Amyloid Light Chain Amyloidosis

enthalten in: ResearchSquare.com | 2022

von Li, X. | Huang, B. | Liu, J. | +3

8

Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis

enthalten in: Journal of cancer research and clinical oncology | 2022

von Li, X. | Huang, B. | Liu, J. | +3

9

Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT

enthalten in: Frontiers in oncology | 2022

von Sun, Q. | Li, X. | Gu, J. | +4

10

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study

in: Integrative Cancer Therapies | 2022

von Li Xiaozhe MD | Chen Meilan MD | Huang Beihui MD | +4

1
2
3
4
5
6
7
Nächster »
[7]